Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder / Dong-Jing Fu en The Journal of Clinical Psychiatry, Año 2015 - Vol.76 - No.3 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.3 (Marzo) . - pp. 253-262 Título : Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder Tipo de documento: texto impreso Autores: Dong-Jing Fu, Autor ; Ibrahim Turkoz, Autor ; Bruce Simonson, Autor Fecha de publicación: 2020 Artículo en la página: pp. 253-262 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno bipolar, Terapia farmacológica, combinación, Isoxazoles, Palmitato de paliperidona - administración y dosificación, Trastornos psicóticos. Resumen: Schizoaffective disorder is a complex illness for which optimal treatment is not well established. Results of the first controlled, relapse-prevention study of paliperidone palmitate once-monthly injectable (paliperidone monthly) in schizoaffective disorder are presented. Link: ./index.php?lvl=notice_display&id=21819 [artículo] Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder [texto impreso] / Dong-Jing Fu, Autor ; Ibrahim Turkoz, Autor ; Bruce Simonson, Autor . - 2020 . - pp. 253-262. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.3 (Marzo) . - pp. 253-262 Palabras clave: Antidepresivos, Trastorno bipolar, Terapia farmacológica, combinación, Isoxazoles, Palmitato de paliperidona - administración y dosificación, Trastornos psicóticos. Resumen: Schizoaffective disorder is a complex illness for which optimal treatment is not well established. Results of the first controlled, relapse-prevention study of paliperidone palmitate once-monthly injectable (paliperidone monthly) in schizoaffective disorder are presented. Link: ./index.php?lvl=notice_display&id=21819

---

1 (1 - 1 / 1)